Immunome (IMNM) Revenue (2023 - 2025)

Immunome's (IMNM) quarterly Revenue came in at $4.0 million in Q2 2025, up 69.84% YoY from $2.4 million in Q2 2024, and up 37.22% on a QoQ basis from $2.9 million in Q1 2025.

Immunome (IMNM) Revenue (2023 - 2025) Analysis & Trends

Immunome (IMNM) has 3 years of Revenue data on file, last reported at $4.0 million in Q2 2025.

  • Quarterly Revenue rose 69.84% year-over-year to $4.0 million in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 63.29% YoY) and the FY2025 annual result came in at $6.9 million, down 23.23% from the prior year.
  • Revenue rose to $4.0 million in Q2 2025, from $2.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $4.3 million in Q2 2023 to a low of $1.0 million in Q1 2024.
  • A 3-year average of $3.0 million and a median of $2.9 million in 2024 frame the typical range for Revenue.
  • Annual changes were most pronounced in 2024 — Revenue sank 56.47% — and 2025, when it soared 184.35%.
  • Tracing IMNM's Revenue over 3 years: stood at $3.8 million in 2023, then slipped by 28.44% to $2.7 million in 2024, then surged by 46.64% to $4.0 million in 2025.
  • The last three Revenue figures came in at $4.0 million (Q2 2025), $2.9 million (Q1 2025), and $2.7 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.56 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.71 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,001.92
7 Royalty Pharma 33.72 Bn 35.84 Bn - 674.14 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.29 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 425.49 Mn
10 Immunome 3.09 Bn 2.57 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 4.02 Mn
Mar 31, 2025 2.93 Mn
Dec 31, 2024 2.74 Mn
Sep 30, 2024 2.91 Mn
Jun 30, 2024 2.36 Mn
Mar 31, 2024 1.03 Mn
Dec 31, 2023 3.83 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 4.26 Mn
Mar 31, 2023 2.36 Mn